People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...

It's yet another perk of these medications.

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...